Supreme Pharma Appears Well Positioned for MMPR Approval

Health Canada’s transition from the Medical Marihuana Access Regulations (“MMAR”) to the Marihuana for Medical Purposes Regulations (“MMPR”) promises to commercialize the production and sale of medical marijuana. Despite hundreds of applications to grow medical marijuana, the regulatory body lists just 13 licensed producers under the new MMPR program on its website. Tweed Marijuana Inc. (OTC: TWMJF) (TSXV: TWD), Bedrocan…

The post Supreme Pharma Appears Well Positioned for MMPR Approval appeared first on Marijuana Index.